Abstract
Because of complexities in platelet serotonin uptake dynamics, we studied the influence of the time of day and year as well as the subject's age on uptake parameters. While the assay itself was quite reproducible, and the kinetic parameters of 5 HT uptake were stable over a few days, at a given time, within an individual, the variance was quite large when samples from different times of the day or year or from different individuals were compared. An inverse relationship between V max (moles/cell number/time) and platelet number was found in data from a group of individuals, suggesting regulation of V max not at the level of uptake capacity per cell, but in a manner that somehow takes into consideration the number of platelets in the subject's plasma. Indeed, expressing V max in a new way (called “total V max”), not based on V max “per cell” or “per 107 cells” but for the total number of platelets in the volume of PRP used, greatly reduced the scatter in the between-individuals and across-time data. While V max (moles/cell number/time) exhibited only a trend toward reduction with age, for example, the decline in total V max with subject age was statistically significant. It is suggested that total V max (moles/time) may be a more physiologically relevant expression for an uptake function than V max (moles/time/cell number).
Similar content being viewed by others
References
Arora RC, Meltzer HY (1981) A modified assay method for determining serotonin uptake in human platelets. Clin Chim Acta 112:225–233
Arora RC, Meltzer HY (1982) Serotonin uptake in subpopulations of normal human platelets. Biol Psychiatry 17:1157–1162
Arora RC, Meltzer HY (1984a) Seasonal variation of serotonin uptake in normal controls and depressed patients. Biol Psychiatry 19:795–804
Arora RC, Meltzer HY (1984b) Genetic control of serotonin (5-HT) uptake but not of imipramine binding in blood platelets of normal twins. Soc Neurosci Abstr 10:893
Arora RC, Tong C, Jackman HL, Stoff D, Meltzer HY (1983) Serotonin uptake and imipramine binding in blood platelets and brain of fawn-hooded and Sprague Dawley rats. Life Sci 33:437–442
Codd EE, Walker RF (1987) Platelet serotonin uptake: methods and strain differences. Psychiatry Res 22:61–67
Corash L, Tan H, Gralnick HR (1977) Heterogeneity of human whole blood platelet subpopulations. I. Relationship between buoyant density, cell volume and ultrastructure. Blood 49:71–87
Egrise D, Rubinstein M, Schoutens A, Cantraine F, Mendlewicz J (1986) Seasonal variation of platelet serotonin uptake and 3H-imipramine binding in normal and depressed subjects. Biol Psychiatry 21:283–292
Gordon JL, Olverman HJ (1978) 5-Hydroxytryptamine and dopamine transport by rat and human blood platelets. Br J Pharmacol 62:219–226
Grant RA, Zucker MB (1979) Altered uptake and release of 14C-serotonin in platelets following incubation of platelet-rich plasma with EDTA. Thromb Res 14:981–986
Guicheney P, Marcel D (1984) Decrease of platelet serotonin content in ovariectomized female rats. Endocrinology 114:2412–2414
Humphries LL, Shirley P, Allen M, Codd EE, Walker RF (1985) Daily patterns of serotonin uptake in platelets from psychiatric patients and control volunteers. Biol Psychiatry 20:1073–1081
Jackson JC, Cross RJ, Walker RF, Markesbery WR, Brooks WH, Roszman TL (1985) Influence of serotonin on the immune response. Immunology 54:505–512
Langer SZ, Briley MS, Raisman R, Henry JF, Morselli PL (1980) Specific 3H-imipramine binding in human platelets. Naunyn Schmiedeberg's Arch Pharmacol 313:189–194
Malmgren R (1981) Methodological aspects of studies on the 5 HT uptake mechanism in normal platelets. Acta Pharmacol Toxicol 49:277–284
Modai I, Malmgren R, Åsberg M, Beving H (1986) Circadian rhythm of serotonin transport in human platelets. Psychopharmacology 88:493–495
Munson PJ, Rodbard D (1980) LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107:220–239
Oxenkrug GH, Prakhje I, Mikhalenko IN (1978) Disturbed circadian rhythm of 5 HT uptake by blood platelets in depressive psychosis. Act Nerv Sup 20:66–67
Rotman A (1983) Blood platelets in psychopharmacological research. Prog Neuropsychopharmacol Biol Psychiatry 7:135–151
Rotman A, Zemishlany Z, Munitz H, Wijsenbeek H (1982) The active uptake of serotonin by platelets of schizophrenic patients and their families: possibility of a genetic marker. Psychopharmacology 77:171–174
Shuttleworth RD, O'Brien JR (1981) Intraplatelet serotonin and plasma 5-hydroxyindoles in health and disease. Blood 57:505–509
Swade C, Coopen A (1980) Seasonal variations in biochemical factors related to depressive illness. J Affect Dis 2:249–255
Walker RF, Codd EE (1985) Neuroimmunomodulatory interactions of norepinephrine and serotonin. J Neuroimmunol 10:41–58
Walker RF, Humphries LL (1984) Patterns of platelet serotonin (5 HT) uptake as influenced by catecholamines. Soc Neurosci Abstr 10:1172
Weissbach H, Redfield BG (1960) Factors affecting the uptake of 5-hydroxytryptamine by human platelets in an inorganic medium. J Biol Chem 235:3287–3291
Wintrobe MM (1974) Clinical hematology. Lea and Febinger, Philadelphia, p 385
Wirz-Justice A, Chappuis-Arndt E (1976) Sex differences in chlorimipramine inhibition of serotonin uptake in human platelets. Eur J Pharmacol 40:21–25
Wirz-Justice A, Richter R (1979) Seasonality in biochemical determinations: A source of variance and a clue to the temporal incidence of affective illness. Psychiatry Res 1:53–60
Wirz-Justice A, Lichtsteiner M, Feer H (1977) Diurnal and seasonal variations in human platelet serotonin in man. J Neural Transm 41:7–15
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Codd, E.E., McAllister, T.W. & Walker, R.F. Factors affecting serotonin uptake into human platelets. Psychopharmacology 95, 180–184 (1988). https://doi.org/10.1007/BF00174506
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00174506